3 minute read
Charing Cross programme seeks new avenues in vascular access and renal care
The role of drug-coated balloons (DCBs) within dialysis access treatment paradigms will be a central focus at this year’s Charing Cross (CX) symposium (25–27 April 2023, London, UK)—while device-created arteriovenous fistulas (AVFs), the latest in vascular access graft technology, and the management of renal artery aneurysms, are all likely highlights from the programme.
The morning section of the CX 2023 programme on Tuesday 25 April— which is set to kick off with the Vascular Access CX Masterclass—will see Ounali Jaffer (Barts Health NHS Trust, London, UK) and Narayan Karunanithy (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) present on the topic of DCBs. The former will query whether there is “too much evidence” in this space, while the latter will broach “the need for more evidence”.
The treatment of arteriovenous access dysfunction in haemodialysis patients will be further examined during later talks by Andrew Holden (Auckland City Hospital, Auckland, New Zealand). Holden is scheduled to present on percutaneous transluminal angioplasty (PTA), an “older technology with newer outcomes”, and will also deliver the latest findings from IN.PACT AV Access trial (Medtronic) following his disclosure of three-year data at last year’s CX symposium.
Elsewhere in vascular access
The Vascular Access CX Masterclass is set to disseminate real-world experiences for physicians looking to integrate endovascular AVF (endoAVF) systems into their care protocols. CX Executive Board member Kate Steiner (East and North Hertfordshire NHS Trust, Stevenage, UK) will discuss “a case-based look at how I have refined my endoAVF creation practice and algorithm”, with a particular focus on patient selection and procedures, followed by Jaffer’s advice on how to add endoAVF creation into a dialysis practice.
Other presentations during the vascular access programme will outline novel technologies and approaches for dialysis patients. Frans Moll (University Medical Center Utrecht, Utrecht, The Netherlands) is scheduled to present Podium First results with “a new kind of graft”, while Matteo Tozzi (University of Insubria, Varese, Italy) will discuss early-cannulation arteriovenous grafts (AVGs) and their role in high-risk failure-to-mature patients. In addition, Gavin Pettigrew (University of Cambridge, Cambridge, UK) will provide CX attendees with an update from the SONAR study—a prospective, observational cohort study intended to determine whether ultrasound surveillance can reliably predict AVF failure in patients with chronic kidney disease.
Dialysis, transplants and aneurysms
The later portion of the first day of CX 2023 will see the programme’s focus expand beyond vascular access to incorporate more general discussions around dialysis, as well as kidney transplantation and renal artery aneurysms.
Peritoneal dialysis (PD)—a modality that has been the subject of ever-increasing interest as many healthcare systems and regions attempt to prioritise home therapies—will be explored by Frank Dor (Imperial College Healthcare NHS Trust, London, UK). Another presentation that looks set to unpack recent changes in kidney care will be delivered by Charmaine Lok (University of Toronto, Toronto, Canada), who plans to examine the evidence surrounding patient-based choices and other aspects of the vascular access treatment algorithm.
The afternoon’s Renal Interventions sessions will also provide an educational element—for example, through Andrew Garnham’s (The Royal Wolverhampton NHS Trust, Wolverhampton, UK) presentation on “training the vascular surgeon for renal patients”. In two separate talks, Robert Jones (Queen Elizabeth Hospital, Birmingham, UK) and Tozzi will further advise their peers on how best to optimise the management and treatment of cephalic arch stenosis, while Jeremy Crane (Imperial College Healthcare NHS Trust, London, UK) is set to posit that “cost effectiveness should be the priority” in this space.
Once again, the latest technologies designed to advance kidney care will feature, with Dirk Hentschel (Brigham and Women’s Hospital, Boston, USA) delivering insights on an implantable, continuous haemofiltration device for dialysis that has also been covered in this issue of Renal Interventions. Turn to page 9 to read more.
Jones will later return to the podium as part of a Masterclass session on “Managing the Renal Artery”. He is set to present the interventional radiology (IR) perspective on renal artery aneurysms, and will be followed by David Kingsmore (Queen Elizabeth University Hospital Trust, Glasgow, UK) outlining the surgical standpoint on this topic. Tuesday’s programme will close with Andrew Willis (Queen Elizabeth Hospital, Birmingham, UK) discussing “Vascular issues with kidney transplant”, with panel discussions and audience participation ultimately seeking to reach a consensus on this subject.
Vascular Access Consensus: Full Day 25th April
Podium First Vascular Access data
“Podium First: IN.PACT AV access trial – 3 year subanalysis data”
Andrew Holden, Auckland, New Zealand
“Podium First: A new kind of graft” Frans Moll, Utrecht, Netherlands
A global perspective
Over 30 expert Faculty members from over 11 countries worldwide
Active audience participation, interaction and polling encouraged – have your say!
“Best of Abstracts” from around the world will be showcased
A new Renal Interventions session highlighting
Lessons learned using stents and balloons
The latest dialysis technology
Training vascular surgeons for renal patients
Masterclass on managing the renal artery
Hands-on practical experience
Hone your skills on Tuesday 25th April within the Vascular Access Workshop, located in the Workshop Wing
Learn from expert demonstrators and get handson time with the latest Vascular Access devices
